Sexual Health

Latest News


Sexual Health and Wellness Consortium

The Sexual Health and Wellness Consortium features a variety of informative videos, articles, podcasts, polls, and quizzes to help you better care for your patients as they navigate their sexual health and wellness journey.

Sexual Health and Wellness Consortium


Osphena (ospemifene) has been approved by the FDA to treat dyspareunia. This is the first non-steroidal estrogen available for women with dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy (VVA) that is common during menopause.

The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.

Yeast infections are one of the most common infections occurring in women. Although they are rarely dangerous, they can be very bothersome and uncomfortable.